These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8095547)

  • 1. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435.
    Takenaka T; Forster H; Epstein M
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1154-9. PubMed ID: 8095547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.
    Takenaka T; Suzuki H; Fujiwara K; Kanno Y; Ohno Y; Hayashi K; Nagahama T; Saruta T
    J Clin Invest; 1997 Oct; 100(8):2107-14. PubMed ID: 9329977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature.
    Yatsu T; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1997 Aug; 29(2):229-32. PubMed ID: 9251904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
    Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T
    Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic characterization of YM435, a novel dopamine DA1 receptor agonist, in anesthetized dogs.
    Yatsu T; Takizawa K; Kasai-Nakagawa C; Uchida W; Tanaka A; Asano M; Honda K; Takenaka T
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):382-8. PubMed ID: 9125677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin.
    Takenaka T; Forster H; Epstein M
    Circ Res; 1993 Oct; 73(4):743-50. PubMed ID: 8396506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney.
    Loutzenhiser R; Hayashi K; Epstein M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):522-8. PubMed ID: 2969977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and pharmacokinetic characteristics of YM435, a novel dopamine DA1-receptor agonist, in anaesthetized dogs.
    Yatsu T; Miyamoto I; Kaneko-Takanuki F; Watanabe T; Takenaka T
    J Pharm Pharmacol; 1997 Sep; 49(9):892-6. PubMed ID: 9306257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of YM435, a dopamine DA1 receptor agonist, in a canine model of ischemic acute renal failure.
    Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1998 Nov; 31(5):803-7. PubMed ID: 9809482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
    Lanese DM; Conger JD
    J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of endothelin on the renal microcirculation.
    Bloom IT; Bentley FR; Wilson MA; Garrison RN
    J Surg Res; 1993 Apr; 54(4):274-80. PubMed ID: 8331921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Video-microscopic assessment of the role of tissue angiotensin-converting enzyme in the control of the renal microcirculation.
    ter Wee PM; Forster HG; Epstein M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):434-9. PubMed ID: 9103527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative sensitivities of isolated rat renal arterioles to endothelin.
    Lanese DM; Yuan BH; McMurtry IF; Conger JD
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F894-9. PubMed ID: 1443178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of YM435, a novel dopamine DA1 receptor agonist, in a canine model of acute congestive heart failure.
    Yatsu T; Arai Y; Sudoh K; Shibasaki M; Uchida W; Inagaki O; Tanaka A; Takenaka T
    Gen Pharmacol; 1998 May; 30(5):733-7. PubMed ID: 9559326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal microvascular actions of calcium antagonists.
    Loutzenhiser R; Epstein M
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S3-12. PubMed ID: 16989072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles.
    Lanese DM; Falk SA; Conger JD
    Transplantation; 1994 Dec; 58(12):1371-8. PubMed ID: 7809931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size-dependent effects of microspheres on vasoconstrictor-mediated change in oxygen uptake by perfused rat hindlimb.
    Vincent MA; Rattigan S; Clark MG
    Microvasc Res; 2001 Nov; 62(3):306-14. PubMed ID: 11678633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of YM435, a novel dopamine D1 receptor agonist, on pancreatic exocrine secretion in anesthetized dogs.
    Iwatsuki K; Ren LM; Chiba S
    Eur J Pharmacol; 1992 Aug; 218(2-3):237-41. PubMed ID: 1425944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulin on rat renal microvessels: studies in the isolated perfused hydronephrotic kidney.
    Hayashi K; Fujiwara K; Oka K; Nagahama T; Matsuda H; Saruta T
    Kidney Int; 1997 May; 51(5):1507-13. PubMed ID: 9150466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered renal microvascular response in Zucker obese rats.
    Hayashi K; Kanda T; Homma K; Tokuyama H; Okubo K; Takamatsu I; Tatematsu S; Kumagai H; Saruta T
    Metabolism; 2002 Dec; 51(12):1553-61. PubMed ID: 12489067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.